Syndax Pharmaceuticals Employee Directory
Biotechnology ResearchNew York, United States201-500 Employees
Syndax Pharmaceuticals is a commercial-stage biopharmaceutical company focused on developing cancer therapies. Headquartered in New York, it operates within the biotechnology research field. Its pipeline features a menin inhibitor intended for relapsed or refractory acute leukemia, as well as a monoclonal antibody that blocks the CSF-1 receptor to address chronic graft-versus-host disease. The organization notes that it is advancing several clinical trials across the treatment continuum to pursue the full potential of its programs. Among recent activities, Syndax announced it will host an R&D Day in New York City on July 14, 2026.